163 related articles for article (PubMed ID: 22084479)
1. Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency.
Chandesris MO; Azarine A; Ong KT; Taleb S; Boutouyrie P; Mousseaux E; Romain M; Bozec E; Laurent S; Boddaert N; Thumerelle C; Tillie-Leblond I; Hoarau C; Lebranchu Y; Aladjidi N; Tron F; Barlogis V; Body G; Munzer M; Jaussaud R; Suarez F; Clément O; Hermine O; Tedgui A; Lortholary O; Picard C; Mallat Z; Fischer A
Circ Cardiovasc Genet; 2012 Feb; 5(1):25-34. PubMed ID: 22084479
[TBL] [Abstract][Full Text] [Related]
2. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
Chandesris MO; Melki I; Natividad A; Puel A; Fieschi C; Yun L; Thumerelle C; Oksenhendler E; Boutboul D; Thomas C; Hoarau C; Lebranchu Y; Stephan JL; Cazorla C; Aladjidi N; Micheau M; Tron F; Baruchel A; Barlogis V; Palenzuela G; Mathey C; Dominique S; Body G; Munzer M; Fouyssac F; Jaussaud R; Bader-Meunier B; Mahlaoui N; Blanche S; Debré M; Le Bourgeois M; Gandemer V; Lambert N; Grandin V; Ndaga S; Jacques C; Harre C; Forveille M; Alyanakian MA; Durandy A; Bodemer C; Suarez F; Hermine O; Lortholary O; Casanova JL; Fischer A; Picard C
Medicine (Baltimore); 2012 Jul; 91(4):e1-e19. PubMed ID: 22751495
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SOCS3 in T lymphocytes leads to impaired interleukin-17 production and severe aortic aneurysm formation in mice--brief report.
Romain M; Taleb S; Dalloz M; Ponnuswamy P; Esposito B; Pérez N; Wang Y; Yoshimura A; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):581-4. PubMed ID: 23329138
[TBL] [Abstract][Full Text] [Related]
4. Coronary artery abnormalities in Hyper-IgE syndrome.
Freeman AF; Avila EM; Shaw PA; Davis J; Hsu AP; Welch P; Matta JR; Hadigan C; Pettigrew RI; Holland SM; Gharib AM
J Clin Immunol; 2011 Jun; 31(3):338-45. PubMed ID: 21494893
[TBL] [Abstract][Full Text] [Related]
5. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.
Renner ED; Rylaarsdam S; Anover-Sombke S; Rack AL; Reichenbach J; Carey JC; Zhu Q; Jansson AF; Barboza J; Schimke LF; Leppert MF; Getz MM; Seger RA; Hill HR; Belohradsky BH; Torgerson TR; Ochs HD
J Allergy Clin Immunol; 2008 Jul; 122(1):181-7. PubMed ID: 18602572
[TBL] [Abstract][Full Text] [Related]
6.
Danion F; Aimanianda V; Bayry J; Duréault A; Wong SSW; Bougnoux ME; Tcherakian C; Alyanakian MA; Guegan H; Puel A; Picard C; Lortholary O; Lanternier F; Latgé JP
Front Immunol; 2020; 11():38. PubMed ID: 32047500
[TBL] [Abstract][Full Text] [Related]
7. STAT3-Deficient hyperimmunoglobulin E syndrome: report of a case with orofacial granulomatosis-like disease.
Carey B; Mercadante V; Fedele S; Glover M; Cale C; Porter S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Nov; 126(5):e252-e257. PubMed ID: 30126807
[TBL] [Abstract][Full Text] [Related]
8. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
Paulson ML; Freeman AF; Holland SM
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
[TBL] [Abstract][Full Text] [Related]
9. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.
Freeman AF; Holland SM
Pediatr Res; 2009 May; 65(5 Pt 2):32R-37R. PubMed ID: 19190525
[TBL] [Abstract][Full Text] [Related]
11. Diminution of signal transducer and activator of transcription 3 signaling inhibits vascular permeability and anaphylaxis.
Hox V; O'Connell MP; Lyons JJ; Sackstein P; Dimaggio T; Jones N; Nelson C; Boehm M; Holland SM; Freeman AF; Tweardy DJ; Olivera A; Metcalfe DD; Milner JD
J Allergy Clin Immunol; 2016 Jul; 138(1):187-199. PubMed ID: 26948077
[TBL] [Abstract][Full Text] [Related]
12. Brain abnormalities in patients with hyperimmunoglobulin E syndrome.
Freeman AF; Collura-Burke CJ; Patronas NJ; Ilcus LS; Darnell D; Davis J; Puck JM; Holland SM
Pediatrics; 2007 May; 119(5):e1121-5. PubMed ID: 17438082
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Role of
Moffitt K; Cheung E; Manis J; Malley R
Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Infections and Surgical Complications in a Young Girl with Signal Transducer and Activator of Transcription 3 Loss-of-Function Mutation Hyperimmunoglobulin E Syndrome: A Case Report.
Toribio-Dionicio C; Cubas-Guzmán D; Guerra-Canchari P; García-Sánchez V; Córdova-Calderón W
Pediatr Allergy Immunol Pulmonol; 2021 Mar; 34(1):33-37. PubMed ID: 33734873
[No Abstract] [Full Text] [Related]
15. Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome.
Patel NC; Gallagher JL; Torgerson TR; Gilman AL
J Clin Immunol; 2015 Jul; 35(5):479-85. PubMed ID: 25962528
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of Pulmonary Aspergillosis in Hyper-IgE Syndrome with Autosomal-Dominant STAT3 Deficiency.
Duréault A; Tcherakian C; Poiree S; Catherinot E; Danion F; Jouvion G; Bougnoux ME; Mahlaoui N; Givel C; Castelle M; Picard C; Chansdesris MO; Lortholary O; Lanternier F;
J Allergy Clin Immunol Pract; 2019; 7(6):1986-1995.e3. PubMed ID: 30878710
[TBL] [Abstract][Full Text] [Related]
17. STAT3 mutations correlated with hyper-IgE syndrome lead to blockage of IL-6/STAT3 signalling pathway.
He J; Shi J; Xu X; Zhang W; Wang Y; Chen X; Du Y; Zhu N; Zhang J; Wang Q; Yang J
J Biosci; 2012 Jun; 37(2):243-57. PubMed ID: 22581330
[TBL] [Abstract][Full Text] [Related]
18. Life-Threatening Pneumopathy and
Deverrière G; Lemée L; Grangé S; Boyer S; Picard C; Fischer A; Marguet C
Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562253
[TBL] [Abstract][Full Text] [Related]
19. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
[TBL] [Abstract][Full Text] [Related]
20. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
Xie L; Hu X; Li Y; Zhang W; Chen L
Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
